Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 22, 2026
Exact Sciences Corporation (EXAS) Presents at 7th Annual Healthcare Symposium Transcript
07:41am, Saturday, 15'th Nov 2025
Exact Sciences Corporation ( EXAS ) 7th Annual Healthcare Symposium November 14, 2025 8:50 AM EST Company Participants David Harding Conference Call Participants Kevin Dreyer - GAMCO Investors, Inc. C
Catherine Wood's Strategic Move: Significant Investment in BitMine Immersion Technologies Inc
05:04pm, Wednesday, 12'th Nov 2025
Exploring the Latest 13F Filing and Investment Strategies Catherine Wood (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, p
Cathie Wood doubles down on Alibaba: ARK Invest snaps up $25M in Chinese tech stocks
07:02am, Wednesday, 12'th Nov 2025
ARK Invest funds boosted holdings in Alibaba (BABA) and Baidu (BIDU) while trimming stakes in Reddit (RDDT), Exact Sciences (EXAS) and Iridium Communications (I
Is Exact Sciences (EXAS) Stock Outpacing Its Medical Peers This Year?
10:41am, Monday, 10'th Nov 2025
Here is how Exact Sciences (EXAS) and Amylyx Pharmaceuticals, Inc. (AMLX) have performed compared to their sector so far this year.
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the expiration of the waiting period under the Hart-Sc
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
10:45am, Saturday, 08'th Nov 2025
Exact Sciences' new launches and big ambitions in the cancer market make it an exciting long-term pick. Roku turned a profit for the first time in years, showing that the streaming platform's strategy
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced pivotal clinical validation results from the ALTUS stu
Earnings Estimates Rising for Exact Sciences (EXAS): Will It Gain?
01:21pm, Wednesday, 05'th Nov 2025
Exact Sciences (EXAS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Here's Why Exact Sciences (EXAS) is a Strong Growth Stock
10:46am, Wednesday, 05'th Nov 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Exact Sciences (EXAS) is an Intriguing Medical Stock to Watch After Q3 Earnings
08:21pm, Tuesday, 04'th Nov 2025
Recognized as a leader in medical diagnostics, the upside potential for Exact Sciences (EXAS) stock has been lifted by its improved operational and financial performance.
Why Exact Sciences Stock Blasted Higher on Tuesday
08:05pm, Tuesday, 04'th Nov 2025
The healthcare diagnostics specialist posted its latest set of quarterly figures. This featured a surprise net profit, among other goodies.
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results
09:25am, Tuesday, 04'th Nov 2025
Exact Sciences Corporation (NASDAQ:EXAS) reported better-than-expected third-quarter financial results and raised its FY25 sales guidance above estimates on Monday.
Exact Sciences to Participate in November Investor Conference
07:00am, Tuesday, 04'th Nov 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the follow
Exact Sciences Corporation (EXAS) Q3 2025 Earnings Call Transcript
02:16am, Tuesday, 04'th Nov 2025
Exact Sciences Corporation ( EXAS ) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Derek Leckow - Vice President of Investor Relations Kevin Conroy - Chairman of The Board & C
Exact Sciences Announces Third Quarter 2025 Results
04:05pm, Monday, 03'rd Nov 2025
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $851 million for
